These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7746000)

  • 1. [Activity or inactivity: is this the question in systemic lupus erythematosus?].
    Cervera R; Font J
    Med Clin (Barc); 1993 Sep; 101(7):255-7. PubMed ID: 7746000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of disease activity in systemic lupus erythematosus].
    Kano S
    Ryumachi; 1996 Feb; 36(1):69-81. PubMed ID: 8711541
    [No Abstract]   [Full Text] [Related]  

  • 3. The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index.
    Davey R; Bamford J; Emery P
    Arthritis Rheum; 2007 Aug; 56(8):2812-3. PubMed ID: 17665430
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Feb; 38(2):275-84. PubMed ID: 21123323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies: do they reflect the severity of systemic lupus erythematosus?
    Piamphongsant T; Charoenvadnasuk S; Roongphiboolsopit P; Pisalbutra P
    J Med Assoc Thai; 1996 Jun; 79(6):370-3. PubMed ID: 8855611
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
    Suh CH; Kim HA
    Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus and discoid lupus erythematosus.
    Powers DB
    Oral Maxillofac Surg Clin North Am; 2008 Nov; 20(4):651-62. PubMed ID: 18940631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to letter by Isenberg and Gordon commenting on the Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus.
    Ruperto N; Ravelli A; Martini A;
    Arthritis Rheum; 2006 Nov; 54(11):3723-4. PubMed ID: 17075891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus].
    Robak E; Kwiecień A; Sysa-Jedrzejowska A
    Przegl Lek; 2005; 62(5):299-305. PubMed ID: 16334536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale.
    Ruiz-Irastorza G; Khamashta MA; Gordon C; Lockshin MD; Johns KR; Sammaritano L; Hughes GR
    Arthritis Rheum; 2004 Feb; 51(1):78-82. PubMed ID: 14872459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for assessing disease activity in systemic lupus erythematosus.
    Isenberg D; Bacon P; Bombardier C; Gladman D; Goldsmith CH; Kalunian K; Liang M; Maddison P; Nived O; Richter M
    J Rheumatol; 1989 Oct; 16(10):1395-6. PubMed ID: 2810268
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional excretion magnesium (FE Mg) in systemic lupus erythematosus.
    Deekajorndech T
    J Med Assoc Thai; 2005 Jun; 88(6):743-5. PubMed ID: 16083212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, disease-specific quality-of-life instrument for patients with SLE.
    Gladman DD
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):132-3. PubMed ID: 16932672
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.